3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Enrolling by invitation
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
5
Gastrointestinal
4
Other
3
Gynecologic
2
Other hematologic neoplasm
1
Lymphoid
1
Head & Neck
1
Conditions
Lymphoma
543
Precursor Cell Lymphoblastic Leukemia-Lymphoma
498
Lymphoma, Non-Hodgkin
437
Lymphoma, Follicular
405
Leukemia, Lymphocytic, Chronic, B-Cell
390
Lymphoma, Large B-Cell, Diffuse
387
Lymphoma, B-Cell
246
Lymphoma, Mantle-Cell
224
Hodgkin Disease
209
Recurrence
207
Leukemia, Myeloid, Acute
196
Leukemia
192
Multiple Myeloma
185
Burkitt Lymphoma
182
Lymphoma, B-Cell, Marginal Zone
170
Neoplasms
151
Myelodysplastic Syndromes
132
Hematologic Neoplasms
117
Waldenstrom Macroglobulinemia
103
Lymphoma, T-Cell, Peripheral
85
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
81
Lymphoma, T-Cell
80
Lymphoma, T-Cell, Cutaneous
64
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
61
Mycosis Fungoides
57
Leukemia, Biphenotypic, Acute
55
Breast Neoplasms
54
Myeloproliferative Disorders
50
Leukemia, B-Cell
50
Lymphoproliferative Disorders
48
Interventions
Angptl4 protein, mouse
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Intermittent Fasting
×
Lymphoid
×
1 year
×
Clear all
NCT06645093
2026-03-10
FasteStudien
University of Oslo
Phase NA
Enrolling by invitation
40 enrolled